TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue March 29, 2013
TCL Archive After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant. November 14, 2008
TCL Archive Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months May 31, 2013
